With reference to the restriction on trading of Venus' shares, Venus Remedies has informed that as per the revised Surveillance Action, now trading is permitted on all trading days with +/-2% price band under Periodic Call Auction. Further, the shortlisting of securities under Enhanced Surveillance Measures is purely on account of market surveillance and it should not be construed as an adverse action against the company.
The above information is a part of company’s filings submitted to BSE.